MS4A18 Inhibitors
MS4A18 inhibitors encompass a broad spectrum of chemical compounds that indirectly influence the functional activity of MS4A18 by targeting various signaling pathways and cellular processes with which MS4A18 may be associated. For example, compounds like Wortmannin and LY294002 directly inhibit PI3K, leading to the suppression of the AKT signaling pathway, a crucial mediator of cellular survival and proliferation signals. If MS4A18 is part of the PI3K/AKT pathway, then inhibitors such as Wortmannin and LY294002 could potentially decrease the activity of MS4A18 by disrupting this signaling cascade. This could lead to downstream effects on cell survival, proliferation, and other cellular functions that are regulated by the PI3K/AKT pathway and potentially involve MS4A18.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin. If MS4A18 function is calcineurin-dependent, cyclosporin A would inhibit MS4A18 by blocking calcineurin activity, which is necessary for the dephosphorylation processes that regulate MS4A18 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. If the function of MS4A18 is regulated by dephosphorylation, okadaic acid would inhibit MS4A18 activity by preventing this essential dephosphorylation step. | ||||||